Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine.

Abstract excerpt

Our understanding of cystic fibrosis (CF) has grown exponentially since the discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in 1989. With evolving genetic and genomic tools, we have come to better understand the role of CFTR genotypes in the pathophysiology of the disease. This, in turn, has paved the way for the development of modulator therapies targeted at mutations in the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Research Advances
• Share to Cystic Fibrosis Transmembrane Conductance Regulator